BCL2L1 and lung cancer: Taken together, our results highlight (i) the sensitivity of lung cancer cells with high activity of the AIF-apoptosis pathway to MTIs, and (ii) the synergistic effect of Bcl-xL and MTIs in lung tumors with initial low activity level of the AIF-apoptosis pathway.